Yair Herishanu, Neta Goldschmidt, Osnat Bairey, Rosa Ruchlemer, Riva Fineman, Naomi Rahimi-Levene, Lev Shvidel, Tamar Tadmor, Aviv Ariel, Andrea Braester, Mika Shapiro, Erel Joffe, Aaron Polliack, and on behalf of the Israeli CLL Study Group. 2015. “Efficacy and Safety of Front-Line Therapy With Fludarabine-Cyclophosphamide-Rituximab Regimen for Chronic Lymphocytic Leukemia Outside Clinical Trials: The Israeli CLL Study Group Experience”. Haematologica 100 (5). Pavia, Italy, 662-69. https://doi.org/10.3324/haematol.2014.115808.